Clinical Trial Update: The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP): The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP) [NA]

View source ↗

Summary

The clinical trial evaluating the Minimally Invasive Micro Sclerostomy (MIMS) System for reducing elevated intraocular pressure in glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• MIMS System

Snippet

Sponsor: Sanoculis Ltd | Conditions: Glaucoma | NA | Status: COMPLETED